DNA-41.04%18.0%
TWST+409.23%15.0%
GENB+0.75%11.0%
CDXS-42.11%10.0%
1548.HK+85.23%9.0%
LNZA-71.87%9.0%
ABSI+263.12%8.0%
688065.SHG-5.90%6.0%
BNN.XETRA+26.48%5.0%
EVGN-57.06%4.0%
WLLW.TO+0.26%3.0%
BICO.ST-24.23%2.0%
As of Aug 24, 2026, 4:53 AM ET
Genomics '25: Synthentic Biology & Biofoundries Constituents
Ginkgo Bioworks Holdings, Inc.DNA | 18.0% | 6.32% | -1.46% | 0.54% | -8.53% | -10.95% | 9.63% | 24.16% | -9.20% | -98.14% | -41.04% | $483.4M |
Twist Bioscience CorporationTWST | 15.0% | 6.79% | 18.25% | 61.28% | 59.03% | 358.98% | 210.29% | 281.03% | 233.46% | 34.69% | 409.23% | $9.07B |
Generate Biomedicines, Inc.GENB | 11.0% | 0.81% | 12.96% | 20.30% | 15.14% | 0.75% | 24.86% | 0.75% | 0.75% | 0.75% | 0.75% | $2.07B |
Codexis, Inc.CDXS | 10.0% | 5.70% | 12.84% | 12.84% | 19.29% | 2.45% | 65.35% | -32.93% | -45.25% | -93.03% | -42.11% | $179.6M |
Genscript Biotech Corporation1548.HK | 9.0% | 3.24% | 40.34% | 113.91% | 90.70% | 175.14% | 187.77% | 178.73% | 184.96% | -3.79% | 85.23% | $9.60B |
LanzaTech Global, Inc.LNZA | 9.0% | 0.48% | 0.48% | 13.02% | 13.22% | -54.58% | -27.07% | -77.76% | -96.39% | -99.37% | -71.87% | $13.7M |
Absci CorporationABSI | 8.0% | 2.91% | 1.49% | 26.32% | 22.75% | 173.64% | 248.54% | 285.08% | 112.69% | -57.35% | 263.12% | $1.62B |
Cathay Biotech Inc.688065.SHG | 6.0% | -2.20% | -6.86% | 6.68% | -0.06% | -5.41% | -15.51% | -2.42% | 39.79% | -55.29% | -5.90% | $4.86B |
BRAIN Biotech AGBNN.XETRA | 5.0% | -6.36% | -4.57% | -2.07% | -7.74% | 4.51% | 3.21% | 20.77% | 56.23% | -75.51% | 26.48% | $67.6M |
Evogene Ltd.EVGN | 4.0% | 0.36% | -19.64% | 4.17% | 19.68% | -48.86% | -36.08% | -55.71% | -85.57% | -97.90% | -57.06% | $4.8M |
Willow Biosciences Inc.WLLW.TO | 3.0% | 0.00% | 0.97% | 2.21% | 1.67% | -0.45% | -1.05% | 3.20% | -2.24% | -8.47% | 0.26% | $3.99B |
BICO Group AB (publ)BICO.ST | 2.0% | 3.63% | 17.04% | 52.96% | 39.28% | -7.92% | 4.09% | -31.66% | -55.62% | -96.62% | -24.23% | $145.7M |
| Theme return | — | 3.02% | 7.92% | 17.41% | 21.40% | 61.73% | 75.78% | 81.52% | 48.14% | -48.16% | 50.29% | — |
| Average | 8.3% | 1.81% | 5.99% | 26.01% | 22.04% | 48.94% | 56.17% | 49.44% | 27.80% | -54.17% | 45.24% | $2.67B |
| Median | 8.5% | 1.86% | 1.23% | 12.93% | 17.22% | 0.15% | 6.86% | 1.98% | -0.75% | -66.43% | -2.82% | $1.05B |
| Std Dev | 4.6% | 3.63% | 14.76% | 32.82% | 27.75% | 117.81% | 96.04% | 120.81% | 99.47% | 45.83% | 139.23% | $3.36B |
| Min | 2.0% | -6.36% | -19.64% | -2.07% | -8.53% | -54.58% | -36.08% | -77.76% | -96.39% | -99.37% | -71.87% | $4.8M |
| Max | 18.0% | 6.79% | 40.34% | 113.91% | 90.70% | 358.98% | 248.54% | 285.08% | 233.46% | 34.69% | 409.23% | $9.60B |
| % Positive Tickers | 75.00% | 66.67% | 91.67% | 75.00% | 50.00% | 66.67% | 58.33% | 50.00% | 16.67% | 50.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Genomics '25: Synthentic Biology & Biofoundries tracks 12 publicly listed stocks in this theme: DNA, TWST, GENB, CDXS, 1548.HK, LNZA, ABSI, 688065.SHG, BNN.XETRA, EVGN, WLLW.TO, BICO.ST. See the constituent table for details.